Research Studies
Current Studies with Open Enrollment
CATARACT STUDIES
Alcon C-07-45
Clinical Study of the Acrysof II Natural IQ IOL
Participating Doctors: Colby Stewart, M.D., Fiaz Zaman, M.D.
Coordinator: Santa Montelongo (832) 553-7133
C-07-43
A Clinical Safety and Efficacy Comparion of NEVANAC® 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients.
Participating Doctors: Steven Dunn, M.D., Lindsey Harris, M.D. (retina exam), Kevin Jong, M.D., Bailey Lee, M.D. (retina exam), John Lim, M.D., Richard Ou, M.D., Mitchell Porias, M.D.
Coordinator: Christina Arnold, COT (832) 553-7140
OCULAR SURFACE / ALLERGIES STUDIES
Novartis Protocol AIN457C
A 24-week multicenter, randomized, double-masked, placebo controlled study to assess the difference in the rate of recurrent exacerbations in Behcet’s patients with posterior or panuveitis treated with AIN 457 Vs Placebo adjunctive to standard-of-care immunosuppressive therapy
Participating Doctors: Susan E. Wittenberg, M.D., Lindsey D. Harris, M.D., Bailey L. Lee, M.D.
Coordinator: Yvette Degley Lead 832-553-7100 (Santa Montelongo 832-553-7133)
Alcon Protocol C-07-40
An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA.
Participating Doctors: Carlos Gonzales, M.D., John Goosey, M.D., Fiaz Zaman, M.D.
Coordinator: Yvette Degley (832) 553-7100 or Santa Montelongo (832) 553-7133
Alcon C-07-53
An evaluation of the efficacy and safety of Al-46383-A Ophthalmic Solution for the treatment of Adenoviral conjunctivitis.
Participating Doctors: Steven Dunn, M.D., John Goosey, M.D., Jeffrey Lanier, M.D., Aaron Miller, M.D., Mark Vital, M.D.
Coordinator: Santa Montelongo (832) 553-7133 LEAD (Yvette Degley (832) 553-7100 or Christina Arnold (832) 553-7133). Jorie Jackson will be handling the Tomball study for Dr. Dunn and Dr. Miller (281) 351-5468.
Alcon C-08-077
AL-38583 Ophthalmic Solution for Dry Eye.
Participating Doctors: Jeffrey Lanier, M.D., Mark Vital, M.D., Fiaz Zaman, M.D.
Coordinator: Yvette Degley (832) 553-7100 LEAD (Santa Montelongo (832) 553-7133 or Christina Arnold (832) 553-7140).
Allergan 192371-016
Evaluating the Efficacy and Safety of Cyclosporine Ophthalmic Solution 0.010% in patients with Atopic Conjunctivitis.
Participating Doctors: John Goosey, M.D., Jeffrey Lanier, M.D., Mark Vital, M.D.
Coordinator: Santa Montelongo (832) 553-7133 or Yvette Degley (832) 553-7100
CONTACT LENS SOLUTION
Bausch & Lomb Protocol 636
A Study to Evaluate the Clinical Performance of a Novel Multipurpose Solution.
Participating Doctors: Deanna Pena-Garcia, OD/Principal Investigator
Coordinator: Yvette Degley Lead 832-553-7100 (Santa Montelongo 832-553-7133)
Bausch & Lomb Protocol 603
A Study to Evaluate the Clinical and Microbial Efficacy of Besifloxacin Opthalmic Suspension, 0.6%, BID Compared to Vehicle in the treatment of Bacterial Conjunctivitis.
Participating Doctors: W. Colby Stewart, MD/Principal Investigator, Robert B. Wilkins, MD/Sub-Investigator, Malcolm L. Mazow, MD/Sub-Investigator, John D. Goosey, MD/Sub-investigator
Coordinator: Yvette Degley Lead 832-553-7100 (Santa Montelongo 832-553-7133)
Bausch & Lomb protocol 550
A clinical safety and efficacy evaluation of Zylet ® (Loteprednol Etabonate 0.5% and Tobramycin 0.3% ophthalmic Suspension) compared to Lotemax ® (Loteprednol etabonate ophthalmic suspension 0.5%), Tobramycin Ophthalmic solution USP, 0.3% and the vehicle of Zylet ® for the treatment of Blepharoconjunctivitis in Pediatric Subjects
Participating Doctors: Carlos A. Gonzales, M.D., James Z. Lai, M.D., Kathryn Musgrove, M.D.
Coordinator: Christina Arnold, COT/Lead Study Coordinator (memorial city office) 832-553-7140 Yvette Degley, Lead Study coordinator (gramercy location) 832-553-7133, Santa Montelongo, Back-up.
